Mar 21 |
Armata Pharmaceuticals reports Q4 results
|
Mar 21 |
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
|
Feb 21 |
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit
|
Nov 14 |
Armata Pharmaceuticals GAAP EPS of -$0.86, revenue of $1.2M
|
Nov 14 |
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
|
Oct 30 |
Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference
|